文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症集束化治疗管理与实践方案的构建及应用

[Construction and application of sepsis bundle therapy management and practice program].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2024-01-01
一句话结论基于德尔菲法构建的脓毒症集束化治疗管理与实践方案可提高1、3、6小时集束化完成率,缩短ICU住院时间并降低ICU住院费用。

该研究通过文献回顾和德尔菲法专家函询构建了包含4项一级、15项二级、34项三级指标的脓毒症集束化治疗管理与实践方案。将2022年1-7月ICU收治的90例脓毒症患者作为对照组(常规集束化治疗护理),2023年1-7月的90例作为干预组(实施构建的方案)。干预组1小时、3小时、6小时集束化完成率均高于对照组(53.30% vs. 21.10%、92.20% vs. 80.00%、88.89% vs. 65.56%,均P<0.05),ICU住院时间缩短[7.00(4.00,14.00)天 vs. 8.00(7.00,20.00)天,P<0.01],ICU住院费用降低[4.63(3.36,6.19)万元 vs. 6.46(3.32,11.34)万元,P<0.05],28天死亡率有降低趋势(33.33% vs. 46.67%,P>0.05)。

要点

  • 构建的方案含4项一级、15项二级、34项三级指标,两轮函询问卷回收率均为100%。
  • 干预组1小时集束化完成率53.30% vs. 对照组21.10%,3小时92.20% vs. 80.00%,6小时88.89% vs. 65.56%(均P<0.05)。
  • 干预组ICU住院时间7.00(4.00,14.00)天 vs. 对照组8.00(7.00,20.00)天,P<0.01。
  • 干预组ICU住院费用4.63(3.36,6.19)万元 vs. 对照组6.46(3.32,11.34)万元,P<0.05。
  • 28天死亡率干预组33.33% vs. 对照组46.67%,差异无统计学意义(P>0.05),有降低趋势。

适用人群与场景

  • 新疆医科大学第一附属医院ICU收治的脓毒症患者,对照组为2022年1-7月收治的90例,干预组为2023年1-7月收治的90例。

处置流程与药物剂量

  • 对照组采用脓毒症常规集束化治疗和护理策略。
  • 干预组在对照组治疗护理策略基础上实施经德尔菲函询法构建的脓毒症集束化治疗管理与实践方案。

研究设计与关键结果

  • 研究类型:方案构建(德尔菲专家函询)联合临床回顾-前瞻对照研究;构建阶段于2022年10-11月进行两轮专家函询,采用Likert 5级评分。
  • 方案构建结果:最终方案含4项一级指标、15项二级指标、34项三级指标;两轮问卷回收率均为100%;专家权威系数分别为0.948和0.940;各条目变异系数分别为0-0.287和0-0.187;肯德尔和谐系数分别为0.242和0.249,均有统计学意义(均P<0.05)。
  • 临床应用:两组年龄、性别、感染部位、病原菌种类、机械通气时间、序贯器官衰竭评分(SOFA)、急性生理学与慢性健康状况评分Ⅱ(APACHEⅡ)等基线资料差异均无统计学意义。
  • 集束化完成率:干预组1小时完成率53.30% vs. 对照组21.10%,3小时完成率92.20% vs. 80.00%,6小时完成率88.89% vs. 65.56%,均P<0.05。
  • 炎症指标:两组C反应蛋白(CRP)、白细胞计数(WBC)、降钙素原(PCT)、白细胞介素-6(IL-6)在不同时间点、组间及交互效应差异均有统计学意义。
  • 预后指标:干预组ICU住院时间7.00(4.00,14.00)天 vs. 对照组8.00(7.00,20.00)天,P<0.01;干预组ICU住院费用4.63(3.36,6.19)万元 vs. 对照组6.46(3.32,11.34)万元,P<0.05;28天死亡率干预组33.33% vs. 对照组46.67%,差异无统计学意义(P>0.05)。

证据类型、等级与局限

  • 证据类型:德尔菲专家函询构建方案联合回顾-前瞻性临床对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,构建的脓毒症集束化治疗管理与实践方案可提高集束化治疗完成率、缩短脓毒症患者ICU住院时间、降低ICU住院费用,并有降低28天死亡率的趋势。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To construct a bundled therapy management and practice program for sepsis and explore its clinical application effect.

METHODS: (1) Construction of sepsis bundled therapy management and practice program: a project team was established to conduct literature review, select experts, compile and distribute questionnaires, organize, analyze expert opinions, and ensure quality control throughout the research process. From October to November 2022, expert letter consultation was carried out, and questionnaires were distributed and collected by on-site filling and WeChat. The Likert 5-point scale was used to rate each item. (2) Clinical application of the protocol: ninety patients with sepsis admitted to the intensive care unit (ICU) of the First Affiliated Hospital of Xinjiang Medical University from January to July 2022 were retrospectively selected as the control group, and routine bundle treatment and nursing strategy for sepsis were adopted. Ninety patients with sepsis admitted from January to July 2023 were prospectively selected as the intervention group. Based on the treatment and nursing strategy of the control group, sepsis bundled therapy management and practice program constructed using the Delphi inquiry method was implemented. The completion rate of 1-hour, 3-hour and 6-hour bundle, the levels of inflammatory indicators at 1, 3, 7 days of treatment, and prognostic indicators were compared between the two groups.

RESULTS: (1) Construction of sepsis bundled therapy management and practice program: the final plan consists of 4 primary indicators, 15 secondary indicators and 34 tertiary indicators. The response rates for both rounds of inquiry questionnaires were 100%. The coefficients of expert authority value were 0.948 and 0.940, respectively. The coefficient of variation for each item was 0-0.287 and 0-0.187, respectively. Kendall's W coefficients were 0.242 and 0.249, respectively, with statistical significances (all P < 0.05). (2) Clinical application of the protocol: there were no statistically significant differences in baseline data such as age, gender, infection site, pathogen species, duration of mechanical ventilation, sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation II (APACHE II) between the two groups. The completion rate of 1-hour, 3-hour and 6-hour bundle in the intervention group were higher than those in the control group (1-hour bundle completion rate: 53.30% vs. 21.10%, 3-hour bundle completion rate: 92.20% vs. 80.00%, 6-hour bundle completion rate: 88.89% vs. 65.56%, all P < 0.05). The levels of C-reactive protein (CRP), white blood cell count (WBC), procalcitonin (PCT), and interleukin-6 (IL-6) in two groups of patients showed statistically significant differences at different time points, between groups, and in interaction effects. Compared with the control group, the length of ICU stay in the intervention group was significantly shortened [days: 7.00 (4.00, 14.00) vs. 8.00 (7.00, 20.00), P < 0.01], and the hospitalization cost of ICU was significantly reduced [ten thousand yuan: 4.63 (3.36, 6.19) vs. 6.46 (3.32, 11.34), P < 0.05]. The 28-day mortality in the intervention group was lower than that in the control group (33.33% vs. 46.67%), but the difference was not statistically significant (P > 0.05).

CONCLUSIONS: The constructed bundled therapy management and practice program for sepsis can improve the completion rate of bundle treatment, shorten the length of ICU stay of sepsis patients, reduce the hospitalization cost in ICU, and have a tendency to reduce the 28-day mortality.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Yang Y, Gu X, Peng H, et al. [Construction and application of sepsis bundle therapy management and practice program]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38845494. doi:10.3760/cma.j.cn121430-20231027-00917

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。